Literature DB >> 2900032

Distribution of Ha-RAS-1 proto-oncogene alleles in breast cancer patients and in a control population.

G Saglio1, C Camaschella, M Giai, A Serra, A Guerrasio, B Peirone, P Gasparini, U Mazza, R Ceppellini, N Biglia.   

Abstract

The frequencies of 13 different Ha-ras proto-oncogene alleles have been estimated in 92 breast cancer patients and 60 unaffected individuals. The Ha-ras alleles can be identified using a DNA restriction fragment length polymorphism (RFLP) closely linked to the 3' end of the gene, and are characterized by a different length due to a region of sequences repeated a variable number of times (variable tandem repeats, VTR). The statistical analysis of the data obtained shows that the frequency of alleles ranging between specific length limits is significantly higher in breast cancer patients than in controls. The same applies to specific genotypes bearing the aforementioned alleles. This suggests that the inheritance of these alleles may be associated with an increased risk of developing breast cancer.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2900032     DOI: 10.1007/bf01805838

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  21 in total

1.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

2.  Unique allelic restriction fragments of the human Ha-ras locus in leukocyte and tumour DNAs of cancer patients.

Authors:  T G Krontiris; N A DiMartino; M Colb; D R Parkinson
Journal:  Nature       Date:  1985 Jan 31-Feb 6       Impact factor: 49.962

3.  T24 human bladder carcinoma oncogene is an activated form of the normal human homologue of BALB- and Harvey-MSV transforming genes.

Authors:  E Santos; S R Tronick; S A Aaronson; S Pulciani; M Barbacid
Journal:  Nature       Date:  1982-07-22       Impact factor: 49.962

4.  Ha-ras hypervariable alleles in myelodysplasia.

Authors:  S L Thein; D G Oscier; J Flint; J S Wainscoat
Journal:  Nature       Date:  1986 May 1-7       Impact factor: 49.962

Review 5.  Oncogenes in human cancers and in chemically induced animal tumors.

Authors:  M Barbacid
Journal:  Prog Med Virol       Date:  1985

6.  Monoclonal antibodies of predefined specificity detect activated ras gene expression in human mammary and colon carcinomas.

Authors:  P H Hand; A Thor; D Wunderlich; R Muraro; A Caruso; J Schlom
Journal:  Proc Natl Acad Sci U S A       Date:  1984-08       Impact factor: 11.205

7.  Loss of alleles at loci on human chromosome 11 during genesis of Wilms' tumour.

Authors:  A Koufos; M F Hansen; B C Lampkin; M L Workman; N G Copeland; N A Jenkins; W K Cavenee
Journal:  Nature       Date:  1984 May 10-16       Impact factor: 49.962

8.  Transformation of NIH 3T3 cells by microinjection of Ha-ras p21 protein.

Authors:  D W Stacey; H F Kung
Journal:  Nature       Date:  1984 Aug 9-15       Impact factor: 49.962

9.  Harvey ras genes transform without mutant codons, apparently activated by truncation of a 5' exon (exon -1).

Authors:  K Cichutek; P H Duesberg
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

10.  Amplified expression of p21 ras protein in hormone-dependent mammary carcinomas of humans and rodents.

Authors:  M E DeBortoli; H Abou-Issa; B E Haley; Y S Cho-Chung
Journal:  Biochem Biophys Res Commun       Date:  1985-03-15       Impact factor: 3.575

View more
  4 in total

Review 1.  Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibility.

Authors:  M M de Jong; I M Nolte; G J te Meerman; W T A van der Graaf; J C Oosterwijk; J H Kleibeuker; M Schaapveld; E G E de Vries
Journal:  J Med Genet       Date:  2002-04       Impact factor: 6.318

2.  Population genetics of the HRAS1 minisatellite locus.

Authors:  B Devlin; T Krontiris; N Risch
Journal:  Am J Hum Genet       Date:  1993-12       Impact factor: 11.025

3.  Ha-ras-1 alleles in Norwegian lung cancer patients.

Authors:  D Ryberg; T Tefre; S Ovrebø; V Skaug; L Stangeland; A Naalsund; R Baera; A L Børresen; A Haugen
Journal:  Hum Genet       Date:  1990-11       Impact factor: 4.132

4.  Polymorphisms of H-ras-1 and p53 in breast cancer and lung cancer: a meta-analysis.

Authors:  A Weston; J H Godbold
Journal:  Environ Health Perspect       Date:  1997-06       Impact factor: 9.031

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.